Royal Philips acquired Remote Diagnostic Technologies for an undisclosed price in a deal set to expand the Amsterdam-based electronics giant’s position in the resuscitation and emergency care market.
Details of the acquisition weren’t disclosed, the company said, though it estimates the resuscitation and emergency care arena to be about $1.6 billion.
Remote Diagnostics (RDT), which was founded in 1997 and employs about 100 people, focuses on prehospital acute care, including primary patient stabilization, at the scene medical treatment, and transportation to hospitals.
"With its focus on the pre-hospital market, RDT’s portfolio of emergency care solutions will enable Philips to grow its presence in this market, as we further build our health technology portfolio and extend the range of connected, data-driven solutions we offer to our customers,” Arman Voskerchyan, head of Philips’ Therapeutic Care unit, said in a statement.
With the deal, Philips will get RDT’s products designed for ambulance and emergency responders that includes the Tempus ALS, a modularized monitor and defibrillator that is a smaller, lighter and more flexible package. RDT also offers other lightweight monitors equipped with telecommunication capabilities for various emergency responders.
Earlier this month, Philips bought EPD Solutions in a deal that could be worth up to $539 million—$293 million upfront and a possible additional $246.2 million if certain milestones are reached. California-based EPD makes cardiac imaging and navigation systems designed to aid electrophysiologists in navigating the heart through a detailed 3D image of the cardiac anatomy.